European Union Cancer Prevalence

Cancer	Cases	Crude	ASR (E)	ASR (W)	Deaths	Crude	ASR (E)	ASR (W)
All sites but skin	1,580,096	421.57	338.83	238.85	929,992	248.12	186.54	123.93
Bladder *	73,132	19.51	14.7	9.78	29,773	7.94	5.44	3.35
Brain, nervous System	28,866	7.7	6.91	5.66	21,681	5.78	4.97	3.77
Breast	210,631	56.2	48.84	35.38	73,592	19.63	15.57	10.61
Cervix Uteri *	22,618	11.8	10.3	8.08	10,098	5.27	3.97	2.83
Colon / Rectum *	217,526	58.04	44.04	29.36	111,781	29.82	21.38	13.63
Corpus Uteri (Uterus) *	37,411	19.51	15.35	10.87	8,998	4.69	2.94	1.89
Hodgkin’s disease	8,407	2.24	2.13	2.01	2,251	0.6	0.49	0.36
Kidney etc	46,228	12.33	10.1	7.21	22,418	5.98	4.54	3.03
Larynx	23,304	6.22	5.45	3.92	10,326	2.75	2.28	1.59
Leukaemia	43,518	11.61	9.55	7.52	29,714	7.93	5.97	4.2
Liver	31,057	8.29	6.41	4.37	34,132	9.11	6.81	4.51
Lung	196,836	52.52	42.16	29.12	183,653	49	38.27	25.96
Melanoma of Skin	38,213	10.2	8.89	6.81	9,010	2.4	1.94	1.37
Multiple Myeloma	21,426	5.72	4.36	2.92	15,259	4.07	2.93	1.88
Non-Hodgkin lymphoma	52,440	13.99	11.5	8.46	25,906	6.91	5.24	3.55
Oesophagus *	24,812	6.62	5.38	3.71	22,917	6.11	4.85	3.29
Oral Cavity and pharynx (mouth) *	53,556	14.29	12.71	9.28	20,178	5.38	4.64	3.31
Ovary etc	34,468	9.2	7.74	5.6	22,999	6.14	4.78	3.23
Pancreas	41,340	11.03	8.35	5.53	45,599	12.17	9.02	5.88
Prostate	144,504	38.55	27.77	17.97	56,035	14.95	9.73	5.72
Stomach *	70,798	18.89	14.13	9.35	54,919	14.65	10.58	6.81
Testis	8,810	2.35	2.25	2.13	641	0.17	0.15	0.13
Thyroid	16,311	4.35	3.99	3.22	3,245	0.87	0.63	0.41
* Lifelinger Technology is most applicable

Table 1 EUCAN Cancer incidence, mortality and prevalence in the European Union 1998 – All ages -Both Sexes

From < http://www-dep.iarc.fr/eucan/eucan.htm

For more cancer statistics (e.g. mortality) see
http://www-dep.iarc.fr/dataava/infodata.htm

How to interpret cancer data

Population at risk

The part of a population which is susceptible to have a specific cancer. It is defined on the basis of demographic data, such as place of residence, sex, age group, etc.

Incidence

The incidence is the number of new cancer cases arising in a given period in a specified population. This information is collected routinely by cancer registries.

Mortality

The mortality is the number of cancer deaths occurring in a given period in a specified population.

Prevalence

The prevalence of cancer is the number of cancer cases in a given population at a specified point in time. It depends on the incidence and on the duration of the disease, that is, on survival.

Crude Rate

Data on incidence or mortality are often presented as rates. For a specific tumour and population, a crude rate is calculated simply by dividing the number of new cancers or cancer deaths observed during a given time period by the corresponding number of people in the population at risk. For cancer, the result is usually expressed as an annual rate per 100,000 persons at risk.

Age-standardized rate

An age-standardized rate (ASR) is a summary measure of a rate that a population would have if it had a standard age structure. Standardization is necessary when comparing several populations that differ with respect to age because age has such a powerful influence on the risk of cancer. The most frequently used standard population are the World and the European standard populations. The calculated incidence or mortality rate is then called World Standardized incidence or mortality rate. It is also expressed per 100,000.

Cumulative rate

Cumulative incidence is the probability or risk of individuals getting the disease during a specified period. For cancer, it is expressed as the number of new born children (out of 100, or 1000) who would be expected to develop a particular cancer before the age of 65 (or 70, or 75) if they had the rates of cancer currently observed. Like the age standardized rate, it permits comparisons between populations of different age structures.